KEYNOTE-641: Phase III study of pembrolizumab plus enzalutamide for metastatic castration-resistant prostate cancer

DSpace Repository

KEYNOTE-641: Phase III study of pembrolizumab plus enzalutamide for metastatic castration-resistant prostate cancer

Author: Graff, Julie N.; Liang, Li Wen; Kim, Jeri; Stenzl, Arnulf
Tübinger Autor(en):
Stenzl, Arnulf
Published in: Future Oncology (2021), Bd. 17, H. 23, S. 3017-3026
Verlagsangabe: Future Medicine Ltd
Language: English
Full text: http://dx.doi.org/10.2217/fon-2020-1008
ISSN: 1744-8301
DDC Classifikation: 610 - Medicine and health
Dokumentart: Artikel
Show full item record

This item appears in the following Collection(s)